Rydex Health Care Fund Class C (RYHCX)

Fund Assets	19.53M
Expense Ratio	2.40%
Min. Investment	$2,500
Turnover	244.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	Dec 16, 2025

Previous Close	109.35
YTD Return	15.43%
1-Year Return	29.28%
5-Year Return	19.54%
52-Week Low	86.18
52-Week High	109.35
Beta (5Y)	0.70
Holdings	135
Inception Date	Mar 30, 2001

About RYHCX

Rydex Health Care Fund Class C is a sector-focused mutual fund specializing in investments within the U.S. healthcare industry. Its primary objective is to achieve capital preservation and appreciation by allocating its portfolio predominantly to companies involved in healthcare, including pharmaceuticals, biotechnology, medical equipment, and related services. The fund offers exposure to an industry known for its defensive characteristics and ongoing innovation, serving investors seeking to participate in the healthcare sector's growth. With total assets of approximately $19.2 million and an expense ratio of around 2.38%, the fund is actively managed to navigate the unique challenges and opportunities presented by this dynamic sector. Rydex Health Care Fund Class C plays a specialized role in the financial markets by providing targeted access to healthcare equities, catering to investors who wish to diversify their portfolios or focus on health-related themes without directly purchasing individual stocks.

• Fund Family: Rydex Funds
• Category: Health
• Performance Rating: Average
• Risk Rating: Average
• Stock Exchange: NASDAQ
• Ticker Symbol: RYHCX
• Share Class: Class C
• Index: S&P 500 TR

Performance

RYHCX had a total return of 29.28% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.66%.

Equivalent Funds

These are funds that follow the same index from the other major fund companies.

Symbol	Provider	Name	Expense Ratio
FIKCX	Fidelity	Fidelity Advisor Health Care Z	0.56%
FSPHX	Fidelity	Fidelity Select Health Care Portfolio	0.62%
FIJYX	Fidelity	Fidelity Advisor Biotechnology Z	0.58%
FSHCX	Fidelity	Fidelity Select Health Care Services Portfolio	0.67%
FBTAX	Fidelity	Fidelity Advisor Biotechnology A	0.96%

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
RYHIX	Investor Class	1.40%
RYHEX	Class A	1.65%
RYHAX	Class H	1.65%

Top 10 Holdings

24.47% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	4.32%
Johnson & Johnson	JNJ	3.42%
AbbVie Inc.	ABBV	2.99%
UnitedHealth Group Incorporated	UNH	2.64%
Merck & Co., Inc.	MRK	2.42%
Thermo Fisher Scientific Inc.	TMO	1.91%
Amgen Inc.	AMGN	1.85%
Abbott Laboratories	ABT	1.68%
Gilead Sciences, Inc.	GILD	1.65%
Vertex Pharmaceuticals Incorporated	VRTX	1.59%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 16, 2025	$2.99915	Dec 16, 2025
Dec 20, 2022	$1.88996	Dec 20, 2022
Dec 8, 2021	$4.23477	Dec 8, 2021
Dec 9, 2020	$10.14672	Dec 9, 2020
Dec 11, 2018	$1.51173	Dec 11, 2018
Dec 12, 2017	$7.88517	Dec 12, 2017

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Aug 27, 2026

Data Sources Report a data error